MedTrace Logo

Intravenous Indocyanine Green for Localization of Intra-thoracic Lesions

NCT03097627 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2017-12-12

No results posted yet for this study

Summary

This is a clinical trial to evaluate the intravenous administration of indocyanine green (ICG) as a method of intra-thoracic lesion localization. The primary purpose is to determine if intravenous ICG allows us to identify intra-thoracic lesions.

Conditions

  • Pulmonary Nodule, Solitary
  • Pulmonary Nodule, Multiple

Interventions

DRUG

ICG Intervention

The intervention to be administered is the drug indocyanine green.

DEVICE

Near Infrared Camera

The intervention to detect the administered drug, indocyanine green.

Sponsors & Collaborators

  • Brigham and Women's Hospital

    lead OTHER

Principal Investigators

  • Yolonda Colson, MD, PhD · Brigham and Women's Hospital

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-01
Primary Completion
2016-10-28
Completion
2016-10-28
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03097627 on ClinicalTrials.gov